Answers are grounded in this paper and cite their sources.
PURPOSE: Conventional predictors such as age and AFC fail to fully explain the substantial inter-individual variability in in vitro fertilization outcomes. This prospective exploratory study investigated whether integrating systemic and local inflammatory biomarkers-specifically calprotectin measured in plasma and follicular fluid-with conventional clinical parameters improves the prediction of cumulative clinical pregnancy. METHODS: We prospectively enrolled consecutive patients undergoing in vitro fertilization and analyzed 75 completed cycles in which all retrieved oocytes and resulting embryos were used. Calprotectin concentrations were quantified in plasma and follicular fluid collected at oocyte retrieval. We evaluated associations with cumulative clinical pregnancy using univariable and multivariable logistic regression. Predictive models obtained were internally validated using a bootstrapping procedure to estimate optimism-corrected discrimination. RESULTS: Age and antral follicle count confirmed their established predictive roles, whereas calprotectin concentrations alone showed no significant association with cumulative pregnancy. In multivariable models, follicular fluid calprotectin showed a negative trend with pregnancy probability, whereas plasma calprotectin showed the opposite trend. Combining age, antral follicle count, and inflammatory parameters yielded strong discriminative performance; after bootstrap correction, the optimism-corrected area under the curve reached 0.862 for the peri-retrieval model and 0.841 for the post-fertilization model. Heatmap visualizations highlighted distinct risk patterns across age strata and inflammatory profiles. CONCLUSIONS: Integrating local and systemic inflammatory biomarkers with conventional clinical predictors provides complementary insights into in vitro fertilization success, suggesting that local microenvironmental stress and systemic immune activation exert divergent effects on reproductive potential. These exploratory, hypothesis-generating findings require confirmation in larger, prospective cohorts. TRIAL REGISTRATION: ClinicalTrials.gov NCT06872294. Registered 20 March 2025.
No takes yet. Share an insight, caveat, or question.
Omes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: